ANTITUMORMIDDEL OG FORSTÆRKER AF ANTITUMORVIRKNING
Provided is a novel method for treating a cancer using an FTD/TPI combination drug, which shows remarkably excellent antitumor effect and small adverse effects.An antitumor agent, in which a combination drug containing trifluridine and tipiracil hydrochloride at a molar ratio of 1 : 0.5 and an anti-...
Gespeichert in:
1. Verfasser: | |
---|---|
Format: | Patent |
Sprache: | dan |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Provided is a novel method for treating a cancer using an FTD/TPI combination drug, which shows remarkably excellent antitumor effect and small adverse effects.An antitumor agent, in which a combination drug containing trifluridine and tipiracil hydrochloride at a molar ratio of 1 : 0.5 and an anti-VEGF antibody or anti-EGFR antibody are administered in combination. |
---|